Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy

OBJECTIVE: To assess the intraocular pressure (IOP)-lowering effect of travoprost 0.004%/timolol 0.5% fixed-dose combination (TRAV/TIM–FC) in patients not achieving the target IOP of ≤18 mmHg while on timolol 0.5% (TIM) monotherapy. METHODS: A multicenter, prospective, open-label study (NCT01336569)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordão, Marcelo Lopes da Silva, Hatanaka, Marcelo, Ogundele, Abayomi, de Moraes Silva, Maria Rosa Bet, Vessani, Roberto Murad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144930/
https://www.ncbi.nlm.nih.gov/pubmed/25170245
http://dx.doi.org/10.2147/OPTH.S66613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144930/
https://www.ncbi.nlm.nih.gov/pubmed/25170245
http://dx.doi.org/10.2147/OPTH.S66613

Ejemplares similares